| Role |
Name |
Disclosure |
Details |
| Author | Richard E Frye, MD, PhD, Assistant Professor, Departments of Pediatrics and Neurology, University of Texas Health Science Center at Houston | Nothing to disclose | Details | | Coauthor | Serge A Jabbour, MD, Department of Medicine, Division of Endocrinology, Associate Professor, Thomas Jefferson University | Nothing to disclose | Details | | Medical Editor | Elena Citkowitz, MD, PhD, FACP, Associate Clinical Professor of Medicine, Yale University School of Medicine; Director, Cardiac Rehabilitation, Director, Cholesterol Management Center, Department of Medicine, Hospital of St Raphael | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Kent Wehmeier, MD, Professor, Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, St Louis University School of Medicine | Nothing to disclose | Details | | CME Editor | Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Serge A Jabbour, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kent Wehmeier, Managing Editor |
The contributor discloses no conflict of interest. |
|